|
Questions and Answers on USP 797
Questions and
Answers on USP 797: Answers Provided by Eric S. Kastango,
MBA, RPh, FASHP:
-
E13
Question: When wiping down a laminar flow hood, are
there any specifications as to the type of wipes that
are allowed?
-
E13 Answer:
The language in the proposed
changes in USP Chapter 797 says "All cleaning tools,
such as wipers, sponges, and mops, are nonshedding and
dedicated to use in the buffer or clean area. Floor mops
may be used in
both the buffer or clean area and anteroom area, but
only in that order. Most wipers are discarded after one
use. If cleaning tools are reused,
their cleanliness is maintained by thorough rinsing and
disinfecting after use and by storing in a clean
environment between uses." There are a number of
vendors (ITW-TexWipe,
www.texwipes.com) who can provide you with more
information about wipers.
(Answer provided as a courtesy
to usp797.org by Eric S. Kastango, MBA, RPh, FASHP. Please
note that usp797.org is not responsible for this answer.)
-
About Eric S. Kastango: Since its
inception, Eric S. Kastango has been at the forefront of
USP <797>. He is an elected member of the United States
Pharmacopoeia Sterile Compounding Committee (2005-2010).
Over the years, he has held multiple American Society of
Health-System Pharmacists chairmanships and committee
positions. He was responsible for creating the
“Comprehensive Sterile Compounding Compliance Gap
Analysis and Risk Assessment Tool.” In this capacity,
Mr. Kastango frequents pharmacy events as an expert
speaker, contributes to industry journals, and teaches.
Mr. Kastango received his Bachelor of Science in
Pharmacy degree from the Massachusetts College of
Pharmacy and Allied Health Sciences and a MBA from the
University of Phoenix. Since 1980, he has practiced
pharmacy in a number of practice settings (including
hospitals, community, and home care) in a number of
different of roles, including the Corporate Vice
President of Pharmacy Services for Coram Healthcare
Corporation, which has 72 pharmacies in 44 states. He
has also managed a FDA-registered cGMP manufacturing
operation for Baxter Healthcare Corporation, and has
made over 100 presentations on a variety of pharmacy
practice topics. Mr. Kastango is the President and CEO
of Clinical IQ, and can be reached as follows:
Mr. Eric
S. Kastango – President and CEO
Clinical IQ, LLC
184 Columbia Turnpike, #282
Florham Park, NJ 07932
Tel: (973) 765-9393
---
www.clinicaliq.com
|